Daiichi Sankyo Healthcare to Market New OTC Gastrointestinal Drug.Tokyo, Japan, June 13, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Daiichi Sankyo Healthcare announced on June 12 that it will launch Senlock Tablet, an over-the-counter gastrointestinal drug, on June 14. The new product, which contains cetraxate hydrochloride hydrochloride /hy·dro·chlo·ride/ (-klor´id) a salt of hydrochloric acid. hy·dro·chlo·ride n. A compound resulting from the reaction of hydrochloric acid with an organic base. , improves blood flow in gastric mucosa gastric mucosa, n the lining of the stomach. and alleviates heavy stomach and stomachache stom·ach·ache n. Pain in the stomach or abdomen. stomachache Vox populi Gastralgia . The drug is available in two sizes. The 30-tablet and 60-tablet bottles retail for 945 yen ($8.25) and 1,575 yen ($13.80), respectively. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion